Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients.
about
Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?Hypomagnesaemia, the kidney and the vesselsAging and vascular endothelial function in humansAssessment of vascular function in patients with chronic kidney disease.Coagulation activation, depletion of platelet granules and endothelial integrity in case of uraemia and haemodialysis treatmentIncreased circulating endothelial apoptotic microparticle to endothelial progenitor cell ratio is associated with subsequent decline in glomerular filtration rate in hypertensive patients.Peripheral vascular dysfunction in chronic kidney diseaseAssociation between noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver disease.Reduction of circulating endothelial progenitor cell level is associated with contrast-induced nephropathy in patients undergoing percutaneous coronary and peripheral interventions.Vascular endothelial function and blood pressure regulation in afferent autonomic failureXyloketal B attenuates atherosclerotic plaque formation and endothelial dysfunction in apolipoprotein e deficient mice.Kidney function decline in the elderly: impact of lipoprotein-associated phospholipase A(2).Association of pulse pressure, arterial elasticity, and endothelial function with kidney function decline among adults with estimated GFR >60 mL/min/1.73 m(2): the Multi-Ethnic Study of Atherosclerosis (MESA)CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches.Additive Effect of Non-Alcoholic Fatty Liver Disease on Metabolic Syndrome-Related Endothelial Dysfunction in Hypertensive Patients.Long-Term Exposure to Ambient Fine Particulate Matter and Renal Function in Older Men: The Veterans Administration Normative Aging Study.Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?Recent findings on the effects of marine-derived n-3 polyunsaturated fatty acids on urinary albumin excretion and renal function.Asymmetric dimethylarginine, endothelial dysfunction and renal diseaseHypomagnesemia, chronic kidney disease and cardiovascular mortality: pronounced association but unproven causation.Clinical Considerations for the Association between Vascular Damage and Chronic Kidney Disease.Serum Endocan as a Predictive Marker for Decreased Urine Volume in Peritoneal Dialysis Patients.Aging Male Spontaneously Hypertensive Rat as an Animal Model for the Evaluation of the Interplay between Contrast-Induced Acute Kidney Injury and Cardiorenal Syndrome in Humans.Renal sympathetic denervation guided by renal nerve stimulation to treat ventricular arrhythmia in CKD patients with ICD.Plasma levels of marine n-3 polyunsaturated fatty acids and renal allograft survival.Aldehyde dehydrogenase 2 as a potential protective factor for renal insufficiency in Japanese subjects with heart failure: a pilot study.Assessing the accuracy of the OMRON HEM-907XL oscillometric blood pressure measurement device in patients with nondialytic chronic kidney disease.Renal function and incidence of chronic kidney disease in HIV patients: a Danish cohort study.Mildly decreased glomerular filtration rate is associated with poor coronary collateral circulation in patients with coronary artery disease.Endothelial dysfunction in individuals born after fetal growth restriction: cardiovascular and renal consequences and preventive approaches.Cardiovascular Safety in Drug Development: A Role for Endothelial Function Tests.Endothelial dysfunction promotes the transition from compensatory renal hypertrophy to kidney injury after unilateral nephrectomy in mice.Vascular Function and Uric Acid-Lowering in Stage 3 CKD.Role of Hyperglycemia-Induced Advanced Glycation End Product (AGE) Accumulation in Atherosclerosis
P2860
Q26748992-62A4416B-81B1-4CE8-9F44-26722A4AADE4Q26853709-063CF18F-E2B9-4704-BBFF-38D2CF12794FQ28390251-5019B5DE-29B5-43D7-BCFE-8751BB037E80Q34323504-BCE1A60B-4BCC-4B81-9E17-8DE7893A5843Q34640247-A0FEAD11-B6C1-4D86-B859-E85CA757F223Q34849981-1FB0452C-2E9C-4A2F-ADA6-D624F2EC5236Q35012914-3FBAC86E-7017-4F17-938C-6D7707594731Q35092860-47FBAA1B-8C8D-4A76-8A69-D29CE6E03D95Q35124843-B9831B24-BEDA-4616-BE41-2E1418DB29EFQ35171817-57DE3190-3D01-480E-A651-64B5C8BEDE4AQ35548908-835E98FB-7DF0-4CE8-A1D8-B3E14124E3B4Q35576334-A8301FB1-B060-4E9E-87CB-8F9782E06805Q35624204-650E97EE-80CC-41AA-AE2C-E13C5135EF3EQ36426077-D43096D3-8FC0-4C0E-A602-45B1E2579528Q36846905-9E4F5457-C6C4-4B5E-8319-2F1201C06D81Q37230324-2B3DE1EF-04D9-4219-A8ED-1258FF969629Q37616714-2A40C07C-D1D5-4DF8-86C9-3C2BC5B4285DQ38034098-B5485158-96C5-469B-8030-C7C33967EBF2Q38056493-4F6C2379-5DB0-4AA7-AD1B-E78FBE45420FQ38196961-8550B84F-E387-44CE-854D-9DE684A0776EQ38639795-9E945669-D1A0-43D2-A73C-9ADAEA5BE44AQ38876082-C8AC3FCC-F6AF-4975-901E-C85D9ADCD29CQ39043950-C89C0213-9646-463A-BB91-546C9D3E0EEDQ41036358-5C7836BB-8828-4A0F-8229-EDE384BE971BQ41305172-64BAEEAD-392A-4510-B4AF-2D28B06F1DD9Q45947623-DB897C80-7493-4DA0-807B-AC3D8F514B9AQ48359742-1F2236D8-A93F-45AE-AC19-EB1F4895FDE6Q50556589-D0203407-4793-4093-9E98-B4AF061E4D9EQ51535218-17B1E5A4-E7FD-42B9-B8C2-F12FFDC9E5DDQ52773759-077DE3C7-C899-452B-8ACA-BC84C6FD788AQ53139178-C2DBBA4B-8808-4108-A79B-D2832077F0B1Q54526289-B4FBB981-3E50-4F6F-94DE-F96D65D71012Q55077663-8C7527EF-DFD5-4A94-855D-B13DA1736F71Q58551068-B2C3BC12-1844-4A2D-B50F-055E8C8D1121
P2860
Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Endothelial dysfunction and su ...... rate in hypertensive patients.
@en
Endothelial dysfunction and su ...... rate in hypertensive patients.
@nl
type
label
Endothelial dysfunction and su ...... rate in hypertensive patients.
@en
Endothelial dysfunction and su ...... rate in hypertensive patients.
@nl
prefLabel
Endothelial dysfunction and su ...... rate in hypertensive patients.
@en
Endothelial dysfunction and su ...... rate in hypertensive patients.
@nl
P2093
P50
P1433
P1476
Endothelial dysfunction and su ...... rate in hypertensive patients.
@en
P2093
Angela Sciacqua
Ermal Shehaj
Francesco Perticone
Paola Naccarato
P304
P356
10.1161/CIRCULATIONAHA.110.940932
P407
P577
2010-07-12T00:00:00Z